URGN
UroGen Pharma Ltd
41.60$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.79 | -3.12 | 0.35 | -0.98 | -2.37 | -3.46 | -4.86 | -3.80 | -3.84 | -2.65 | -2.26 | -3.38 | |
| 0.01 | 0.05 | 0.02 | 0.02 | 0.03 | 0.06 | 0.09 | 0.08 | 0.08 | 0.06 | 0.03 | 0.05 | |
| 0.13 | 0.19 | 0.16 | 0.65 | 1.95 | 1.46 | 1.29 | 1.03 | 0.46 | 0.32 | 0.31 | 0.25 | |
| 0.11 | 2.08 | 0.39 | 0.67 | 1.95 | 1.46 | 1.24 | 1.03 | 0.50 | – | – | – | |
| -0.07 | 0.26 | 0.10 | 0.39 | 0.45 | 0.21 | -0.29 | -0.59 | -0.28 | 0.12 | 0.12 | -0.58 | |
| 0.01 | 0.13 | 0.06 | 0.03 | 0.04 | 0.02 | 0.06 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 0.00 | -0.13 | -0.07 | -3.74 | 2.24 | -7.09 | 4.28 | 0.18 | 0.05 | -0.03 | -0.48 | 1.28 | |
| 26.62 | 9.37 | 0.05 | 6.34 | 4.23 | 8.05 | 0.76 | 0.00 | 0.06 | – | – | – | |
| 0.28 | – | – | – | -0.01 | – | 0.00 | 0.00 | 4.20 | 0.00 | 0.57 | -0.04 | |
| 2.15 | 9.37 | 0.00 | 6.34 | 4.22 | 8.05 | 0.76 | 3.24 | 4.26 | 4.06 | 4.54 | 0.83 | |
| 0.36 | 6.12 | 0.28 | 1.61 | 4.09 | -2.50 | 0.18 | -0.38 | 0.47 | 1.37 | 1.80 | -1.27 | |
| -1.80 | -3.25 | 0.29 | -1.01 | -2.41 | -3.48 | -4.92 | -3.83 | -3.85 | -2.66 | -2.26 | -3.38 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.